MARK-ID
ActiveSummary
MARK-ID has been active since 2011 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €103,261 and a net result of €8,877. Equity is growing by about 5.2% per year across the filed financial years. Its solvency ranks better than 89% of 39,131 sector peers (NACE 70, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
02-07
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
31-12
Financial
Equity above €100,000equity €103,261 ▲9.4%
A profit in every financial year since 2018 builds equity to €103,261.
23-07
NBB filing
Annual accounts filed
financial year 2024 · micro format
2024
01-07
NBB filing
Annual accounts filed
financial year 2023 · micro format
2023
14-07
NBB filing
Annual accounts filed
financial year 2022 · micro format
2022
30-06
NBB filing
Annual accounts filed
financial year 2021 · micro format
2021
12-07
NBB filing
Annual accounts filed
financial year 2020 · micro format
2020
31-12
Financial
Weakest financial yearnet €1,650 ▼77.6%
Net result drops to €1,650, the lowest in the series; recovery starts the following year.
07-07
NBB filing
Annual accounts filed
financial year 2019 · micro format
2019
31-12
Financial
Liquidity more than triplescurrent ratio 9.00
Current ratio from 2.48 to 9.00; short-term debt falls from €29,341 to €6,621.
01-07
NBB filing
Annual accounts filed
financial year 2018 · micro format
2018
02-07
NBB filing
Annual accounts filed
financial year 2017 · micro format
2017
26-06
NBB filing
Annual accounts filed
financial year 2016 · micro format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 14 annual accounts filed, the latest 10 are here; all 14 are under Financials.
0 of 3 deeds read
About the unread acts
We know of 3 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.